Skip to main content
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 2001 Oct 31;128(1):61–63. doi: 10.1007/s004320100286

Isolated brain metastases as the sole manifestation of a late relapse in breast cancer

Charbel M Issa 1, R Semrau 1, R Kath 1, K Höffken 1
PMCID: PMC12164399  PMID: 11862474

Abstract

We report on a 62-year-old female patient suffering from breast cancer (invasive ductal, premenopausal, estrogen- and progesterone-receptor status unknown) first diagnosed in July 1991. After mastectomy and axillary lymphonodectomy (pT2 N2 (12/15) M0 G2), adjuvant chemotherapy consisting of six courses epirubicin and cyclophosphamide was performed. Since 1993, serum Ca 15–3 levels began to climb slowly. As of June 1996, Ca 15–3 was measured 50.1 U/ml (normal value <28.0 U/ml). In routine follow-ups, Ca 15–3 increased slowly, but no metastases of the breast cancer could be detected. In September 2000, the patient attended a routine follow-up examination with poor performance status, presenting with ataxia and a psychic syndrome. Computed tomography revealed multiple suprasellar brain metastases. We conclude that this is an unusual case of a very late clinical manifestation of sole brain metastases in a patient with breast cancer. A slow preceding increase of Ca 15–3-level over a period of 7 years was the only indicator of the upcoming brain metastases.

Keywords: Breast cancer Brain metastases Ca 15–3

Footnotes

Electronic Publication


Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES